Jesper Bøje Andersen

Jesper Bøje Andersen

Professor


  1. Published

    Stromal yin-yang of myofibroblasts and endothelial cells in the progression of intrahepatic cholangiocarcinoma

    Andersen, Jesper Bøje, 2022, In: Hepatology. 76, 5, p. 1233-1236

    Research output: Contribution to journalEditorialResearch

  2. Published

    The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma

    Correnti, M., Cappon, A., Pastore, M., Piombanti, B., Lori, G., Oliveira, D. V. P. N., Munoz-Garrido, P., Lewinska, M., Andersen, J. B., Coulouarn, C., Sulpice, L., Peraldo Neia, C., Cavalloni, G., Quarta, S., Biasiolo, A., Fassan, M., Ramazzotti, M., Parri, M., Recalcati, S., di Tommaso, L. & 6 others, Campani, C., Invernizzi, P., Torzilli, G., Marra, F., Pontisso, P. & Raggi, C., 2022, In: Liver International. 42, 1, p. 233-248

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology

    Duwe, Lea, Fouassier, L., Lafuente Barquero, Juan Francisco & Andersen, Jesper Bøje, 2022, In: Translational Oncology. 26, 13 p., 101531.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities

    Høgdall, Dan Taksony Solyom, O'Rourke, Colm & Andersen, Jesper Bøje, 2022, Advances in Cancer Research. Academic Press, Vol. 156. p. 343-366 (Advances in Cancer Research).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  5. Published

    Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer

    Høgdall, Dan Taksony Solyom, O'Rourke, Colm, Larsen, F. O., Zarforoushan, S., Christensen, Troels Dreier, Ghazal, A., Boisen, M. K., Muñoz-Garrido, P., Johansen, Julia Sidenius & Andersen, Jesper Bøje, 2022, In: Journal of Hepatology. 77, p. 1047-1058 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Izquierdo-Sanchez, L., Lamarca, A., La Casta, A., Buettner, S., Utpatel, K., Klümpen, H-J., Adeva, J., Vogel, A., Lleo, A., Fabris, L., Ponz-Sarvise, M., Brustia, R., Cardinale, V., Braconi, C., Vidili, G., Jamieson, N. B., Macias, R. I., Jonas, J. P., Marzioni, M., Hołówko, W. & 24 others, Folseraas, T., Kupčinskas, J., Sparchez, Z., Krawczyk, M., Krupa, Ł., Scripcariu, V., Grazi, G. L., Landa-Magdalena, A., Ijzermans, J. N., Evert, K., Erdmann, J. I., López-López, F., Saborowski, A., Scheiter, A., Santos-Laso, A., Carpino, G., Andersen, Jesper Bøje, Marin, J. J., Alvaro, D., Bujanda, L., Forner, A., Valle, J. W., Koerkamp, B. G. & Banales, J. M., 2022, In: Journal of Hepatology. 76, 5, p. 1109-1121

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models

    Olaizola, P., Lee-Law, P. Y., Fernandez-Barrena, M. G., Alvarez, L., Cadamuro, M., Azkargorta, M., O'Rourke, C. J., Caballero-Camino, F. J., Olaizola, I., Macias, R. I. R., Marin, J. J. G., Serrano-Maciá, M., Martinez-Chantar, M. L., Avila, M. A., Aspichueta, P., Calvisi, D. F., Evert, M., Fabris, L., Castro, R. E., Elortza, F. & 5 others, Andersen, Jesper Bøje, Bujanda, L., Rodrigues, P. M., Perugorria, M. J. & Banales, J. M., 2022, In: Journal of Hepatology. 77, 1, p. 177-190

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Lipid alterations in chronic liver disease and liver cancer

    Paul, Bichitra, Lewinska, Monika & Andersen, Jesper Bøje, 2022, In: JHEP Reports. 4, 6, 18 p., 100479.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase–Protein Kinase B Pathway in Chronically Inflamed Liver

    Quintavalle, C., Meyer-Schaller, N., Roessler, S., Calabrese, D., Marone, R., Riedl, T., Picco-Rey, S., Panagiotou, O. A., Uzun, S., Piscuoglio, S., Boldanova, T., Bian, C. B., Semela, D., Jochum, W., Cathomas, G., Mertz, K. D., Diebold, J., Mazzucchelli, L., Koelzer, V. H., Weber, A. & 7 others, Decaens, T., Terracciano, L. M., Heikenwalder, M., Hoshida, Y., Andersen, Jesper Bøje, Thorgeirsson, S. S. & Matter, M. S., 2022, In: Hepatology Communications. 6, 6, p. 1467-1481

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Involvement of Epigenomic Factors in Bile Duct Cancer

    Rogalska-Taranta, Magdalena & Andersen, Jesper Bøje, 2022, In: Seminars in Liver Disease. 42, 2, p. 202-211 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 93714085